U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C17H19NO3
Molecular Weight 285.3377
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of PIPERINE

SMILES

O=C(\C=C\C=C\C1=CC2=C(OCO2)C=C1)N3CCCCC3

InChI

InChIKey=MXXWOMGUGJBKIW-YPCIICBESA-N
InChI=1S/C17H19NO3/c19-17(18-10-4-1-5-11-18)7-3-2-6-14-8-9-15-16(12-14)21-13-20-15/h2-3,6-9,12H,1,4-5,10-11,13H2/b6-2+,7-3+

HIDE SMILES / InChI

Description

Piperine is a simple and pungent alkaloid found in the seeds of black pepper (Piper nigrum). Following its isolation and full characterization, the biological properties of piperine have been extensively studied, and piperine-like derivatives have shown an interesting range of pharmacological activities. Piperine is currently paving its way to become a privileged scaffold for the development of bioactive compounds with therapeutic application in multiple human diseases. In particular, piperine derivatives were shown to modulate the activity of several targets related to neurological disorders, including epilepsy, Parkinson's disease, depression and pain related disorders. Moreover, the efflux pump inhibitory ability of piperine and its analogues tackles important drug resistance mechanisms and may improve the clinical efficacy of antibiotic and anticancer drugs. Piperine has been found to have immunomodulatory, anti-oxidant, anti-asthmatic, anti-carcinogenic, anti-inflammatory, anti-ulcer, and anti-amoebic properties.

CNS Activity

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
14.19 µM [IC50]
2.12 µM [IC50]
133.3 µM [IC50]
45.0 µM [IC50]
230.7 µM [IC50]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown
Palliative
Unknown

Doses

PubMed

Sample Use Guides

In Vivo Use Guide
A single dose of Piperine 20 mg was administered daily for 10 days
Route of Administration: Oral
In Vitro Use Guide
Piperine inhibited the proliferation of SW480 and HT-29 cells in a dose-dependent manner, it had low cytotoxicity on these cell lines with 50 % inhibiting concentration (IC50) values greater than 100 uM. Pretreatment of the cells with 40 uM piperine for 1 h significantly inhibited the mRNA production of CXCL8 in response to LPS stimulation in SW480 and HT-29 cells.